Overview

Comparison of Colesevelam Hydrogen Chloride (HCl) Powder For Oral Suspension Versus Generic Cholestyramine Through Use of the Bile Acid Sequestrant Acceptability (BASA) Scale

Status:
Completed

Trial end date:
2010-06-01

Target enrollment:

Participant gender:

Summary

The objective of this study is to compare the acceptability of Colesevelam HCl powder for oral suspension versus generic cholestyramine via the BASA scale, based upon an anticipated equivalent cholesterol lowering doses of each comparator drug.

Phase:

Phase 4

Details

Lead Sponsor:

Louisville Metabolic and Atherosclerosis Research Center

Collaborators:

Daiichi Sankyo Inc.
Daiichi Sankyo, Inc.
Provident Clinical Research

Treatments:

Bile Acids and Salts
Cholestyramine Resin
Colesevelam Hydrochloride